Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...

Sanofi has initiated a Phase 2a clinical study titled A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate th ...

The outcome of this study could significantly impact Sanofi’s stock performance and investor sentiment, as successful results may enhance their competitive edge in the multiple sclerosis treatment ...

OverviewIn 2025, data science offers lucrative roles across technology, finance, healthcare, and retail.Top careers include ...

Families who have never shared their stories publicly before are speaking out following a series of special reports on ITV ...

With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...

Novel Mechanism Demonstrates Clinically Meaningful Prevention of Weight Rebound and Metabolic Benefits After Stopping GLP-1 Therapy ...